New treatments for influenza
1Center for Gene Regulation in Health and Disease, Cleveland State University, 2351 Euclid Avenue, Cleveland, Ohio 44115, USA. s.barik@csuohio.edu
BMC Medicine
|September 15, 2012
Summary
Influenza viruses constantly change, leading to drug resistance and vaccine evasion. This review explores novel therapeutic strategies targeting influenza based on recent molecular and genomic research.
Area of Science:
- Virology
- Immunology
- Genomics
Background:
- Influenza viruses cause significant global morbidity and mortality.
- High mutation rates and genomic reassortment drive viral evolution, leading to antigenic diversity.
- This diversity allows influenza to evade existing vaccines and antiviral treatments.
Purpose of the Study:
- To review emerging anti-influenza therapeutic strategies.
- To highlight novel targets and creative approaches for influenza treatment.
- To summarize recent molecular and genomic discoveries relevant to therapy.
Main Methods:
- Literature review of recent molecular and genomic discoveries.
- Analysis of prospective therapeutic regimens.
- Synthesis of information on novel targets and strategies.
Main Results:
- Identification of key molecular and genomic factors driving influenza evolution.
- Summary of several promising novel therapeutic targets.
- Overview of innovative treatment strategies under development.
Conclusions:
- New anti-influenza therapies are urgently needed due to viral evolution.
- Recent molecular and genomic insights offer promising avenues for novel treatments.
- Continued research into novel targets and strategies is essential for effective influenza control.
Related Concept Videos
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:51Vaccinations
Overview
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:22Methods of reducing fever
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...